Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -133.63x is 20% above its 3-year average of -166.43x, around the middle of its 3-year range (-592.68x–75.89x).
136.97% below its 12-month average of -56.39x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -57.55x.
INTEREST COVERAGE RATIO
-133.63x
INTEREST COVERAGE RATIO AVG TTM
-56.39x
INTEREST COVERAGE RATIO AVG 3Y
-180.82x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-136.97%
CURRENT VS 3Y AVG
+26.10%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
-1975.00%
vs the sector median at left
Tevogen Bio Holdings Inc.
Market Cap
$27.03M
Interest Coverage Ratio
-133.63x
TTM Avg
-56.39x
3Y Avg
-180.82x
5Y Avg
N/A
Market Cap
$28.08M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$28.10M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$28.31M
Interest Coverage Ratio
-144.28x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$25.22M
Interest Coverage Ratio
-17.20x
TTM Avg
55.75x
3Y Avg
55.75x
5Y Avg
55.75x
Market Cap
$29.37M
Interest Coverage Ratio
-34.72x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$24.60M
Interest Coverage Ratio
N/A
TTM Avg
1.00x
3Y Avg
1.00x
5Y Avg
1.00x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tevogen Bio Holdings Inc. (TVGN) | $27.03M | -133.63x | -56.39x | -180.82x | N/A |
| aTyr Pharma, Inc. (ATYR)vs › | $27.79M | N/A | N/A | N/A | N/A |
| Seres Therapeutics, Inc. (MCRB)vs › | $28.08M | N/A | N/A | N/A | N/A |
| iTonic Holdings Ltd. (ITOC)vs › | $28.10M | N/A | N/A | N/A | N/A |
| OneMedNet Corporation (ONMD)vs › | $28.31M | -144.28x | N/A | N/A | N/A |
| BeyondSpring Inc. (BYSI)vs › | $28.47M | N/A | N/A | N/A | N/A |
| ABVC BioPharma, Inc. (ABVC)vs › | $25.22M | -17.20x | 55.75x | 55.75x | 55.75x |
| Quantum Cyber N.V. (QUCY)vs › | $29.37M | -34.72x | N/A | N/A | N/A |
| InspireMD, Inc. (NSPR)vs › | $24.60M | N/A | 1.00x | 1.00x | 1.00x |
| Context Therapeutics Inc. (CNTX)vs › | $29.57M | N/A | N/A | N/A | N/A |
Interest Coverage
-133.6x
Debt/Equity
N/A
Current Ratio
0.33
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -57.55x |
| 2026-03-31 | 75.89x |
| 2025-12-31 | -65.23x |
| 2025-09-30 | -91.91x |
| 2025-06-30 | -143.15x |
| 2025-03-31 | -421.49x |
| 2024-12-31 | -592.68x |
| 2024-09-30 | -488.44x |
| 2024-03-31 | -189.47x |
| 2023-09-30 | -7.75x |
| 2023-06-30 | -7.28x |
| 2023-03-31 | -8.04x |
